when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LEADING · news · pharmadog

← back to LEADING

News mentioning LEADING

653 stories

Apr 30, 26Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstoodstat

Apr 30, 26Merck still sees ‘compelling’ outlook for Terns leukemia drugbiopharma dive

Apr 30, 26Opinion: Congress must hold RFK Jr. accountable after hearingsstat

Apr 29, 26Food safety experts warn of USDA brain drainstat

Apr 29, 26MPM has collected three China drugs for its ‘best of both worlds’ strategyendpoints

Apr 29, 26Opinion: Why alternative medicine can feel so much better than mainstream health carestat

Apr 28, 26The crown for healthcare admin tech is still up for grabsendpoints

Apr 28, 26Pfizer deals extend patent life for a top-selling rare disease drugbiopharma dive

Apr 28, 26Predicting consequences of new hepatitis B vaccine recsstat

Apr 28, 26Boehringer, Zealand’s obesity shot looks as good as Novo's Wegovy, but weaker than Lilly's Zepboundendpoints

Apr 28, 26Opinion: Why do discussions about ‘brain health’ ignore mental illness?stat

Apr 27, 26New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies projectstat

Apr 27, 26Lilly to buy startup Ajax in bid for a better JAK drugbiopharma dive

Apr 27, 26Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyriziendpoints

Apr 24, 26STAT+: FDA to speed up review of three psychedelics as mental health treatmentsstat

Apr 24, 26Sanofi MS drug rejected in US gets an endorsement in Europebiopharma dive

Apr 24, 26Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learnedstat

Apr 23, 26FDA approves Regeneron’s hearing loss gene therapybiopharma dive

Apr 23, 26Heart’s beat may help it beat cancer, mouse research suggestsstat

Apr 23, 26Novartis' radioligand therapy Lutathera could soon face generic competitionendpoints

Apr 23, 26Sanofi posts upbeat sales as R&D pressure buildsbiopharma dive

Apr 23, 26Endpoints wins Neal Awards for Trump and gene editing coverage, JPM eventendpoints

Dec 22, 25Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series Afiercebiotech

← prevpage 22 of 22next →